Cosmetics and Pregnancy

NCT03283189 | Unknown

• 1 other identifier: CHU-350
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The use of cosmetics is an important source of exposure to many chemicals including endocrine disruptors. Recently, national and international scientific recommendations have been issued to limit exposure to chemicals during pregnancy. However, the perception and the use of cosmetics by pregnant women is still little studied. The objectives of the PERICOS study are to identify the risk perception and the attitudes regarding cosmetic's use by the pregnant women. Understanding the risk perception, the knowledge, attitudes and expectations of women about the use of cosmetics during pregnancy will help to set up effective strategies to improve prevention of chemical exposure.

Conditions

Pregnancy

Keywords

Use of cosmetics; Pregnant women; Risk perception; Preventive attitude; Qualitative study

Outcome Measures

Primary Outcomes (1)

• Pregnant women's views on the risk related to the use of cosmetics

  the perception of the risks linked to the use of cosmetics in general, and creams for striae gravidarum in particular, were investigated during the focus groups interviews.

  at day 1 (during the interview)

Secondary Outcomes (2)

• Cosmetic's use during pregnancy

  at day 1 (during the interview)

• Expectations of pregnant women in terms of information about the use of cosmetics

  at day 1 (during the interview)

Study Arms (6)

Group 1

Pregnancy follow-up in the only maternity type III of the region (CHU) and in an urban area (around Clermont-Ferrand)

Other: Group discussions

Group 2

Pregnancy follow-up in the only maternity type III of the region (CHU) and in an urban area (around Clermont-Ferrand)

Other: Group discussions

Group 3

Pregnancy follow-up in the only private maternity (type II) of the region and in an urban area (around Clermont-Ferrand)

Other: Group discussions

Group 4

Pregnancy follow-up in the only private maternity (type II) of the region and in an urban area (around Clermont-Ferrand)

Other: Group discussions

Group 5

Pregnancy follow-up in a type I maternity and in a rural area (around Saint-Flour)

Other: Group discussions

Group 6

Liberal follow-up of pregnancy

Interventions

Group discussions OTHER

The focus group discussions will be conducted in a private room in the maternity of the women. They will last approximately 2 hours and will be led by an interviewer using an interview grid. All interviews will be audio-recorded.

Group 1; Group 2; Group 3; Group 4; Group 5

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

pregnant women

You may qualify if:

• \- Pregnant women between 22 (≥ 22 weeks) et ≤ 39 weeks of gestation;
• Obstetric management in the Réseau de Santé en Périnatalité d'Auvergne (RSPA);
• At least 18 years;
• Understanding and speaking French;
• And giving their signed agreement of participation.

You may not qualify if:

• Refusal to participate or to be registered during the collective interview;
• Women with fetal death in utero or whose fetus or fetuses have a malformation;
• Women with psychiatric disorders, mental confusion or language disorders making impossible the interview;
• Women with chronic dermatological pathology requiring dermatological care (eczema, psoriasis, etc.).

Sponsors & Collaborators

• University Hospital, Clermont-Ferrand: lead
• Agence Régionale de Santé Rhône-Alpes: collaborator
• Université d'Auvergne: collaborator
• Observatoire Régional de Santé Auvergne-Rhône Alpes (ORS- ARA): collaborator

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

Location

Study Officials

• Cécile MARIE

  University Hospital, Clermont-Ferrand

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Patrick LACARIN

CONTACT

04 73 75 11 95; placarin@chu-clermontferrand.fr

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 8, 2017
• First Posted: September 14, 2017
• Study Start: February 28, 2019
• Primary Completion: December 30, 2019
• Study Completion: December 30, 2019
• Last Updated: February 4, 2019

Record last verified: 2019-02

Locations

FR (1)